CW
BIIB icon

CreativeOne Wealth’s Biogen BIIB Stock Holding History

CreativeOne Wealth’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-865
Closed -$240K – 833
2023
Q1 		$240K Buy
+865
New +$239K 0.01% 702
2021
Q2 		– Sell
-2,321
Closed -$649K – 671
2021
Q1 		$649K Buy
2,321
+144
+7% +$38.8K 0.05% 281
2020
Q4 		$533K Buy
+2,177
New +$562K 0.04% 276

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

CreativeOne Wealth's BIIB Position: Q2 2023 in Review

CreativeOne Wealth sold out of Biogen (BIIB) in Q2 2023, closing a stake of 865 shares — an estimated $240K sold.

CreativeOne Wealth first reported a position in BIIB in Q4 2020 and held it in 3 quarters. The position peaked at $649K in Q1 2021. 1,008 funds tracked by Wall St. Rank hold BIIB as of Q2 2023.

  • CreativeOne Wealth reported no remaining Biogen position as of Q2 2023 after selling out during the quarter.
  • CreativeOne Wealth sold 865 Biogen shares in Q2 2023, an estimated $240K.
  • CreativeOne Wealth first reported a position in Biogen in Q4 2020 and held it in 3 quarters.
  • CreativeOne Wealth's Biogen position peaked at $649K in Q1 2021.
  • 1,008 funds tracked by Wall St. Rank held Biogen as of Q2 2023.

Based on CreativeOne Wealth's 13F filing for Q2 2023, filed 14 Aug 2023.